Becton, Dickinson and Company · BDX · Next earnings

Becton, Dickinson and Company reports Thursday, Nov 5, 2026

BDX reports before market open with consensus EPS at $4.07 and revenue at $5.11B. Last quarter: BD raises FY2026 EPS midpoint as strategic platforms accelerate

Reports Before market open1 day awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $4.07 Calendar consensus
Consensus revenue $5.11B Calendar consensus
Report date Nov 5, 2026 Thursday, date estimated
Session Before market open 1 day away

Where BDX left off: FY2026 Q3

Full report

BD raises FY2026 EPS midpoint as strategic platforms accelerate

EPS surprise +2.9% Reported $3.23 vs $3.14
Revenue surprise +2.0% Reported $4.98B vs $4.89B
Stock move +3.8% Event window
Subsequent drift +6.0% Up to 20 sessions

Management raised the midpoint of FY2026 adjusted EPS guidance and signaled revenue growth toward the high end of its low-single-digit range.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Alaris remediation is expected to remain a headwind, including an estimated 200 basis points in FY2027.
  • China market dynamics and vaccine-demand pressure could weigh on growth.
  • Tariffs and oil-price volatility may affect costs through resin and plastic inputs.

Questions analysts left open

  • Sustainability of Q3 growth into FY2027.
  • Impact of Alaris remediation on future revenue and margins.
  • Macro inflation and oil-based resin costs affecting COGS.
  • Utilization trends across hospitals and diagnostic testing.
  • Capital expenditure expectations and the ability to maintain margin expansion.

Ask FN2 about BDX next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the BDX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent BDX quarters

All BDX earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.